Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats
S. Prashanth1★, A. Anil Kumar1, B. Madhu1, N. Rama1, J. Vidya Sagar1★ Corresponding author
- 1Vaagdevi College of Pharmacy, Vishwambara Educational Society, Ramnagar, Hanmakonda, Warangal - 506 001, A.P, India.
CORRESPONDENCE
S. Prashanth
Vaagdevi College of Pharmacy, Vishwambara Educational Society, Ramnagar, Hanmakonda, Warangal - 506 001, A.P, India.
Volume 2, Issue 1 · pp. 7–8 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.77083
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Aims: To find out the pharmacokinetic and pharmacodynamic drug interaction of carbamazepine, a protype drug used to treat painful diabetic neuropathy with glibenclamide in healthy albino Wistar rats following single and multiple dosage treatment. Materials and Methods: Therapeutic doses (TD) of glibenclamide and TD of carbamazepine were administered to the animals. The blood glucose levels were estimated by GOD/ POD method and the plasma glibenclamide concentrations were estimated by a sensitive RP HPLC method to calculate pharmacokinetic parameters. Results: In single dose study the percentage reduction of blood glucose levels and glibenclamide concentrations of rats treated with both carbamazepine and glibenclamide were significantly increased when compared with glibenclamide alone treated rats and the mechanism behind this interaction may be due to inhibition of P-glycoprotein mediated transport of glibenclamide by carbamazepine, but in multiple dose study the percentage reduction of blood glucose levels and glibenclamide concentrations were reduced and it may be due to inhibition of P-glycoprotein mediated transport and induction of CYP2C9, the enzyme through which glibenclamide is metabolised. Conclusions: In the present study there is a pharmacokinetic and pharmacodynamic interaction between carbamazepine and glibenclamide was observed. The possible interaction involves both P-gp and CYP enzymes. To investigate this type of interactions pre-clinically are helpful to avoid drug-drug interactions in clinical situation.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Prashanth, S., Kumar, A. A., Madhu, B., Rama, N., & Sagar, J. V. (2011). Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats. Journal of Pharmacology and Pharmacotherapeutics, 2(1), 7–8. https://doi.org/10.4103/0976-500X.77083